Free Cash Flow
Cash generated after capital expenditures.
Latest Free Cash Flow: $3.01B (2026Q1); +1827.6% YoY.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Free Cash Flow Data
| Period | Value |
|---|---|
| 2024Q1 | $180M |
| 2024Q2 | $241M |
| 2024Q3 | $2.36B |
| 2024Q4 | $978M |
| 2025Q1 | $156M |
| 2025Q2 | $1.39B |
| 2025Q3 | $6.75B |
| 2025Q4 | $678M |
| 2026Q1 | $3.01B |
Healthcare Comparison
1 / 3
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 8